Protected: Neoadjuvant treatment key to unlocking benefits of PBS-listed Kadcyla® (trastuzumab emtansine) in the adjuvant setting
This content is password protected. To view it please enter your password below: Password:
Author Roche
Roche
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system.
Protected: TECENTRIQ® (atezolizumab) first immunotherapy to be reimbursed for 1L treatment of extensive-stage small cell lung cancer
This content is password protected. To view it please enter your password below: Password:
Protected: Tecentriq® (atezolizumab) + chemotherapy now TGA approved for 1L extensive-stage small cell lung cancer
This content is password protected. To view it please enter your password below: Password: